Literature DB >> 9406816

EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation.

D Peus1, L Hamacher, M R Pittelkow.   

Abstract

Epidermal keratinocyte growth and differentiation are regulated by specific families of growth factors and receptors. Peptide growth factors of the epidermal growth factor family stimulate proliferation of clonal density human keratinocytes and suppress markers of terminal differentiation in confluent cultures of human keratinocytes. We present evidence that selected inhibitors of activation of the type I human epidermal growth factor receptor (EGFR or HER-1), namely, neutralizing monoclonal antibody to HER-1/EGFR and the specific tyrosine kinase inhibitor PD 153035, potently inhibit proliferation of human keratinocytes in autonomously replicating subconfluent cultures. Coupled to growth arrest is the suppression of HER-1 tyrosine autophosphorylation in inhibitor-treated human keratinocytes. Proliferation and tyrosine autophosphorylation are initially reversible following removal of the inhibitor and restimulation of cells with epidermal growth factor. Sustained inactivation of HER-1 in autonomously replicating cultures of human keratinocytes induces expression of keratin 1 and keratin 10 genes, early markers of terminal differentiation. Reversal of growth inhibition by epidermal growth factor suppresses keratin 1 and keratin 10 expression. These results demonstrate that human keratinocyte terminal differentiation as well as proliferation are mediated by HER-1. Co-expression of autocrine epidermal growth factor-related ligands as well as HER-1 by human keratinocyte may function as part of the signal transduction network in epidermis to regulate cell number, replication rate, and terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406816     DOI: 10.1111/1523-1747.ep12340759

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  42 in total

1.  Combined treatment with sodium butyrate and PD153035 enhances keratinocyte differentiation.

Authors:  Sandra Leon Carrion; Carrie Hayes Sutter; Thomas R Sutter
Journal:  Exp Dermatol       Date:  2014-03       Impact factor: 3.960

Review 2.  Asymmetric cell divisions in the epidermis.

Authors:  Nicholas D Poulson; Terry Lechler
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

3.  Pressure sore-like ulcers on acneiform papules caused by EGFR inhibitors.

Authors:  Saori Miyawaki; Mikiko Tohyama; Kazunori Irifune; Ryouji Ito; Koji Sayama
Journal:  Int Wound J       Date:  2013-03-21       Impact factor: 3.315

Review 4.  Recent advances on the roles of epidermal growth factor receptor in psoriasis.

Authors:  Sijia Wang; Zhuoli Zhang; Han Peng; Kang Zeng
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

5.  [Follicular drug reaction from cetuximab: a common side effect in the treatment of metastatic colon carcinoma].

Authors:  M Braun-Falco; C Holtmann; F Lordick; J Ring
Journal:  Hautarzt       Date:  2006-08       Impact factor: 0.751

6.  EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis.

Authors:  Zhonghua Zhang; Chang Xiao; Aaron M Gibson; Stacey A Bass; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

7.  EGFR regulation of epidermal barrier function.

Authors:  Quynh T Tran; Lawrence H Kennedy; Sandra Leon Carrion; Sridevi Bodreddigari; Shirlean B Goodwin; Carrie H Sutter; Thomas R Sutter
Journal:  Physiol Genomics       Date:  2012-03-06       Impact factor: 3.107

Review 8.  Crosstalk of Notch with p53 and p63 in cancer growth control.

Authors:  G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2009-07-16       Impact factor: 60.716

Review 9.  Skin toxicities associated with epidermal growth factor receptor inhibitors.

Authors:  Tianhong Li; Roman Perez-Soler
Journal:  Target Oncol       Date:  2009-05-19       Impact factor: 4.493

10.  A predictive phosphorylation signature of lung cancer.

Authors:  Chang-Jiun Wu; Tianxi Cai; Klarisa Rikova; David Merberg; Simon Kasif; Martin Steffen
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.